Glycated haemoglobin or HbA1c is formed by the reaction of glucose with normal haemoglobin. The amount of HbA1c in red blood cells therefore increases with the average blood glucose concentration.
Poor control of blood glucose levels in diabetes increases the risk of serious complications such as cardiovascular disease, neuropathy and retinopathy.
Measurement of HbA1c is the method of choice for monitoring control of blood glucose levels in diabetic patients.
The Axis-Shield HbA1c turbidimetric immunoassay provides a highly accurate and precise method for measurement of HbA1c in whole blood on any clinical chemistry analyser with a number of convenient features.
Excellent correlation with other HbA1c methods
Total imprecision <4%
No interference from common variants
Two liquid-stable reagents. A 5-level calibrator pack and 2-level control pack are also available.
Direct measurement of HbA1c – no need for separate Hb measurement
Wedge bottles for direct loading onto many chemistry analysers
Simple assay protocol suitable for use on any clinical chemistry platform. Applications available for many platforms including Beckman Coulter, Siemens, Roche Cobas, Konelab
Intended Use
The HbA1c assay is an Immunoturbidimetric immunoassay for the quantitative determination of percent haemoglobin A1c (HbA1c) in human whole blood on clinical chemistry analysers. Percent HbA1c measurements are used for monitoring long-term glycaemic control in diabetic patients.
Assay Principle
The Axis-Shield HbA1c assay utilises the interaction of antigen and antibody to directly determine the concentration of HbA1c (%) in whole blood.